Medical Questions > Lifestyle > Alternative Medicine Forum

U.s. Clears Mylan's Generic Rival to J&j Pain Patch

Must Read
Chronic pain affects more than 70 million Americans. But what is pain? And how can pain management help relieve different types of pain? Basic facts here....
How does the nervous system work to register pain? And what are the major causes of acute and chronic pain? Plus, who's at risk of pain here....
Acute and chronic pain manifest different symptoms. Learn the difference here and know when to seek medical help for pain....
U.S. Regulators approved the first generic rival to johnson & johnson's duragesic pain relief skin patch. Mylan laboratories inc. Will produce several different strengths of the patch, known generically as the fentanyl transdermal system, and launch the product immediately. Johnson & johnson's annual sales of the patch total about $1.63 billion.
Mylan, the biggest u.S. Maker of generic drugs, had hoped to launch its copycat version last year, but the fda granted j&j an additional six months of market exclusivity in return for testing the drug's safety and effectiveness in children.
Has anyone had experience using this?
Did you find this post helpful?
|

replied January 29th, 2007
Re:u.s. Clears Mylan's Generic Rival to J&j Pain Patch
I got an rx yesterday and noticed that the fentanyl in the new patch is solid (the way other patches are). In the old one, there was an actual reservoir in it and it moved around.

I awoke today feeling kind of sweaty and withdrawal-y after applying the new patch 24 hrs ago-- i'm not sure if it works as well. It is smaller, and I know the old patch's strength was based upon how large of an area the patch covered. I don’t think there is any major development in the drugs. It’s just another change of band name. Matter is rightly pointed out in a book “with a license to kill” by john josefson ( presently available at http://www.Lulu.Com/content/587718 )
|
Did you find this post helpful?